Discovered at Berkeley

Eradicating malaria

Taking aim at the global health problem of malaria, which infects 250 million people worldwide every year and kills one child every 45 seconds in Africa alone, UC Berkeley researchers in the frontier field of synthetic biology re-engineered yeast to produce the antimalarial drug artemisinin. The development of this semi-synthetic compound through cutting-edge research and public-private collaboration ensures an affordable, reliable supply of artemisinin, and promises enormous spin-off potential in the production of other drugs, specialty chemicals and fuels.